Literature DB >> 23634357

Multiple sclerosis therapeutic strategies: Start safe and effective, reassess early, and escalate if necessary.

Robert T Naismith1.   

Abstract

Entities:  

Year:  2011        PMID: 23634357      PMCID: PMC3613188          DOI: 10.1212/CPJ.0b013e31823cc2b0

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


× No keyword cloud information.
  5 in total

1.  Anti-JC virus antibodies: implications for PML risk stratification.

Authors:  Leonid Gorelik; Michaela Lerner; Sarah Bixler; Mary Crossman; Brian Schlain; Kenneth Simon; Amy Pace; Anne Cheung; Ling Ling Chen; Melissa Berman; Fairuz Zein; Ewa Wilson; Ted Yednock; Alfred Sandrock; Susan E Goelz; Meena Subramanyam
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

2.  Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Authors:  R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

3.  The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?

Authors:  Eric C Klawiter; Anne H Cross; Robert T Naismith
Journal:  Neurology       Date:  2009-09-22       Impact factor: 9.910

Review 4.  Induction vs. escalating therapy in multiple sclerosis: practical implications.

Authors:  Giancarlo Comi
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

5.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.